News & Media

A warm welcome from myself, Lara, and the entire Calla Lily Clinical Care Team to Precious Kilimo, who joins us as an MBA Intern from London Business School where she is a Mo Ibrahim Foundation Scholar. 🏛 Prior to business school, Precious was instrumental in scaling Maisha Meds, a Kenyan health tech non-profit from a $300k …

When we talk about advancements in healthcare, the vagina doesn’t often make it into the conversation. But it should. Hell, it’s standard dinner conversation at my house. The power of the vagina as a vessel for targeted, effective treatment is an emerging trend in women’s health. A trend geared toward smarter, safer, more effective medication …

Many of you know my drive to co-found Calla Lily Clinical Care was driven by my personal journey as a infertility survivor. The memory that remains particularly vivid is the distress caused by the inadequate methods of administering progesterone— whether through injections, pessaries, tablets, or suppositories. Each option (including now rings) has its pros and …

I feel like Boston is the place to be these days! I made my 3rd trip there in the last year to attend the Women’s Health Innovation Summit in Boston thanks to Kisaco Research and it was inspiring, to say the least. The event assembled leaders, innovators, and passionate professionals all focused on one mission: …

We had an exciting & intense three days at CPHI Milan, connecting with business leaders from across the global life sciences industry, especially those passionate about advancing Womens Health. It was a pleasure to meet with our existing partners in person and explore exciting new materials and suppliers. We also uncovered unique opportunities for collaboration …

I had the great honour of meeting with Linda Griffith, Professor of Biological and Mechanical Engineering, and MacVicar Fellow at Massachusetts Institute of Technology, where she leads the MIT Center for Gynepathology Research. I’ve long been inspired by Professor Griffith’s groundbreaking work, and now, with our progress and dedicated team & lab resources in place, …

It has been an absolute pleasure and privilege participating at the Tommy’s Preterm Birth Policy Lab today hosted by Prof Catherine Williamson and Prof Anna David, moderated by Ross Pow (perfectly on schedule!). Experts from so many disciplines expressed their hopes and highlighted the obstacles on the road towards a real change in preventing PTB. …

We’ve made great strides in bringing in-house the R&D expertise and facilities needed to advance our vaginal drug delivery system. However, external partnerships remain key to achieving our ambitious goals. Our recent visit to Cambridge Design Partnership was a productive opportunity to align on our latest strategy and critical milestones, particularly around GMP manufacturing and …

We’re delighted to welcome Dr. Emma Parry to our team as a Zinc NIHR Innovation Fellow! Emma brings invaluable expertise from her role as a clinical GP in Birmingham and as an academic GP at Royal Wolverhampton Hospitals NHS Trust. As we continue developing our patient-centric vaginal drug delivery system, Emma will play a key …

Just returned from another productive trip to New York, where I also had the chance to pitch our Callavid drug delivery  technology at the New York Venture Summit hosted by Young Startup Ventures at the Javits Center. Beyond engaging with potential investors, it was inspiring to connect with fellow medtech founders and explore exciting new …